Evidence map›Paper›PMID 32178272›Full record

ReviewAntioxidants (Basel, Switzerland)2020

Potential Antidepressant Effects of Scutellaria baicalensis, Hericium erinaceus and Rhodiola rosea.

Fiona Limanaqi, Francesca Biagioni, Carla Letizia Busceti, Maico Polzella, Cinzia Fabrizi, Francesco Fornai

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 79 citations in OpenAlex.

  1. Effects of aJournal of psychopharmacology (Oxford, England) · 2025
    Trial
  2. Trial
  3. Review
  4. Article
  5. Lion's Mane Mushroom (Nutrients · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. The EPMA journal · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Phenolic Compounds ofInternational journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Fiona LimanaqiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126, Pisa, Italy.ORCID 0000-0003-0185-2099
Francesca BiagioniI.R.C.C.S. Neuromed Pozzilli, Via Atinense, 18, 86077, Pozzilli, Italy.ORCID 0000-0003-3566-4889
Carla Letizia BuscetiI.R.C.C.S. Neuromed Pozzilli, Via Atinense, 18, 86077, Pozzilli, Italy.
Maico PolzellaAliveda Laboratories, Viale Karol Wojtyla, 19, 56042 Lorenzana, (PI), Italy.
Cinzia FabriziDepartment of Anatomy, Histology, Forensic Medicine and Orthopedics, Sapienza University of Rome, Via A. Borelli 50, 00161, Rome, Italy.ORCID 0000-0002-6007-754X
Francesco FornaiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126, Pisa, Italy.ORCID 0000-0002-3883-5084
Istituto Neurologico Mediterraneo · ITUniversity of Pisa · ITSapienza University of Rome · IT

Funding

Ministero della Salute Ricerca Corrente 2020
6 · The paper itself

Abstract

Recent studies focused on the pharmacology and feasibility of herbal compounds as a potential strategy to target a variety of human diseases ranging from metabolic to brain disorders. Accordingly, bioactive ingredients which are found within a variety of herbal compounds are reported to produce both neuroprotective and psychotropic activities which may help to combat mental disorders such as depression, anxiety, sleep disturbances and cognitive alterations. In the present manuscript, we focus on three herbs which appear effective in mitigating anxiety or depression with favourable risk-benefit profiles, namely Scutellaria baicalensis (

Indexed as

anti-inflammatoryantioxidantanxietydepressionmonoaminesneurogenesisneuroprotectionneurotrophic factorsphytochemicals

Identifiers

PMID32178272
PMCPMC7139475
OpenAlexW3011545626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.